Correlation Between Protara Therapeutics and Metacrine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Metacrine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Metacrine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Metacrine, you can compare the effects of market volatilities on Protara Therapeutics and Metacrine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Metacrine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Metacrine.

Diversification Opportunities for Protara Therapeutics and Metacrine

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Protara and Metacrine is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Metacrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metacrine and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Metacrine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metacrine has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Metacrine go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Metacrine

If you would invest  188.00  in Protara Therapeutics on August 25, 2024 and sell it today you would earn a total of  51.00  from holding Protara Therapeutics or generate 27.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.44%
ValuesDaily Returns

Protara Therapeutics  vs.  Metacrine

 Performance 
       Timeline  
Protara Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Metacrine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Metacrine has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Metacrine is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Protara Therapeutics and Metacrine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protara Therapeutics and Metacrine

The main advantage of trading using opposite Protara Therapeutics and Metacrine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Metacrine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metacrine will offset losses from the drop in Metacrine's long position.
The idea behind Protara Therapeutics and Metacrine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes